Endothelin-1 is associated with mortality that can be attenuated with high intensity statin therapy in patients with stable coronary artery disease.
Ruizhu LinJuhani JunttilaJarkko PiuholaE Samuli LepojärviJohanna MaggaAntti M KiviniemiJuha PerkiömäkiHeikki HuikuriOlavi UkkolaMikko TulppoRisto KerkeläPublished in: Communications medicine (2023)
Our data suggests a prognostic value for high circulating ET-1 in patients with stable CAD. High intensity statin therapy associates with reduction of risk for all-cause mortality and CV death in CAD patients with high ET-1.